How should I taper a patient who is taking 1 mg alprazolam (Xanax) twice daily, and is prescribing 0.5 mg tablets three times daily appropriate?

Tapering Alprazolam (Xanax) from 1 mg Twice Daily

No, prescribing 0.5 mg three times daily is not appropriate—this maintains the same total daily dose (1.5 mg) rather than reducing it, which defeats the purpose of tapering. Instead, you should implement a gradual hyperbolic taper by reducing the dose by no more than 0.5 mg every 3 days, with some patients requiring even slower reductions 1.

Recommended Tapering Approach

Start by reducing the total daily dose, not redistributing it. The FDA-approved Xanax label explicitly states: "decrease dosage by no more than 0.5 mg every 3 days" 1. This means your first step should be reducing from 2 mg/day total to 1.5 mg/day total—for example, changing to 0.5 mg three times daily (which is what you proposed) OR 1 mg in the morning and 0.5 mg in the evening.

Specific Tapering Schedule

Initial reduction (Week 1):

• Reduce from 1 mg BID (2 mg/day) to 1.5 mg/day total
• Options: 0.5 mg TID, or 1 mg + 0.5 mg split dosing
• Wait at least 3 days before next reduction

Subsequent reductions:

• Continue reducing by 0.5 mg every 3+ days as tolerated
• Example progression: 2 mg → 1.5 mg → 1 mg → 0.5 mg → 0.25 mg → discontinue
• Critical caveat: Many patients require much slower tapers, especially at lower doses

Why Hyperbolic (Proportionate) Tapering Matters

The relationship between benzodiazepine dose and GABA-A receptor activity is hyperbolic, not linear 2. This means equal dose reductions produce increasingly large pharmacological effects as you approach zero. Linear reductions (like 0.5 mg every 3 days) will cause escalating withdrawal symptoms as the dose decreases 2.

At lower doses, you'll need to slow down dramatically:

• When reaching 1 mg/day or less, consider switching to 10-25% reductions of the current dose rather than fixed 0.5 mg cuts
• Final doses may need to be as small as 0.25 mg or less 2
• Use liquid formulations or compounded preparations to achieve these tiny reductions 2, 3

Essential Management Principles

Patient collaboration is non-negotiable 1, 3:

• Obtain informed consent before starting the taper
• Involve the patient in decisions about taper speed and when to pause
• If withdrawal symptoms emerge, pause the taper or return to the previous dose
• Some patients may require months to years for complete discontinuation

Monitor for withdrawal symptoms 1:

• Anxiety, insomnia, tremor, tachycardia
• Abdominal pain, nausea, diaphoresis
• Seizures are possible with rapid tapers—this is life-threatening
• Follow up at least monthly, ideally more frequently 3

Consider adjunctive support 3, 4:

• Cognitive behavioral therapy significantly reduces relapse risk after discontinuation 4
• Peer support resources can be valuable 3
• Address underlying anxiety or panic disorder with non-pharmacologic interventions

Common Pitfalls to Avoid

1. Don't maintain the same total daily dose (your proposed 0.5 mg TID = 1.5 mg/day, which is not a reduction from 2 mg/day)

2. Don't use fixed linear reductions throughout the entire taper—you must slow down at lower doses due to hyperbolic pharmacology 2

3. Don't taper too quickly—the FDA label allows reductions every 3 days, but many patients need weeks or months between reductions, especially those on long-term therapy 1, 5

4. Don't abandon patients who struggle—if the taper fails, reassess rather than discontinuing care 3

5. Don't forget that alprazolam has a short half-life (11.6 hours) 6, making withdrawal symptoms more abrupt than with longer-acting benzodiazepines like diazepam. Consider switching to diazepam for the taper if the patient experiences significant interdose withdrawal 5.

The evidence is clear: benzodiazepine tapering is a marathon, not a sprint 7. Prioritize patient safety and tolerability over speed of discontinuation.